Evidence map›Paper›PMID 36508017›Full record

ArticleArchives of osteoporosis2022

Two-country comparison of the prescription of bone protection medication before and early after hip fracture.

Nicole K Halim, Roger G Harris, Ian D Cameron, Jacqueline Close, Ian A Harris, Jamie Hallen, Sarah Hurring, Nicola Ward, Catherine McDougall, Rebecca J Mitchell

Abstract read
PubMed Publisher
In one paragraph

Article in Archives of osteoporosis, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Data resource profile: Australian and New Zealand Hip Fracture Registry (ANZHFR).Hip international : the journal of clinical and experimental research on hip pathology and therapy · 2026
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 7 institutions in 2 countries.

Nicole K HalimAustralian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Sydney, NSW, 2109, Australia.
Roger G HarrisAustralian and New Zealand Hip Fracture Registry Steering Group, Auckland, New Zealand.
Ian D CameronJohn Walsh Centre for Rehabilitation Research, Northern Sydney Local Health District and Faculty of Medicine and Health, University of Sydney, Sydney, NSW, Australia.
Jacqueline CloseFalls, Balance and Injury Research Centre, Neuroscience Research Australia, University of New South Wales, Sydney, Australia.
Ian A HarrisIngham Institute for Applied Medical Research, School of Clinical Medicine, UNSW Medicine and Health, UNSW, Sydney, Australia.
Jamie HallenFalls, Balance and Injury Research Centre, Neuroscience Research Australia, University of New South Wales, Sydney, Australia.
Sarah HurringCanterbury District Health Board, Christchurch, New Zealand.
Nicola WardAustralian and New Zealand Hip Fracture Registry Steering Group, Auckland, New Zealand.
Catherine McDougallSurgical Treatment and Rehabilitation Service (STARS) and The Prince Charles Hospital, Metro North Hospital and Health Service, Queensland and Faculty of Medicine, University of Queensland, St Lucia, Australia.
Rebecca J MitchellAustralian Institute of Health Innovation, Macquarie University, Level 6, 75 Talavera Road, Sydney, NSW, 2109, Australia. r.mitchell@mq.edu.au.
Accident Compensation Corporation · NZMacquarie University · AUNeuroscience Research Australia · AUCanterbury District Health Board · NZIngham Institute · AUPrince Charles Hospital · AUUniversity of Sydney · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Pharmacological management of bone health warrants investigation into factors influencing initiation of bone protection medication (BPM) at discharge after a hip fracture. This sprint audit identified reasons attributed to low BPM treatment levels at hospital discharge which can guide improvement in the prevention of future fractures. PURPOSE: To compare patient characteristics and Australian and New Zealand approaches to prescribing bone protection medication (BPM) pre- or post-hip fracture, determine reasons why BPM was not prescribed earlier post-fracture, and assess the generalisability of sprint audit and the Australian and New Zealand Hip Fracture Registry (ANZHFR) patient cohorts.

methodsA retrospective cohort study of hip fracture patients from the ANZHFR aged ≥ 50 years (2016-2020) and consecutive patients from the 2021 BPM sprint audit. Multivariable logistic regression was used to examine factors associated with not prescribing BPM.

resultsOf 55,618 patients admitted with a hip fracture in the ANZHFR, less than 10% of patients in Australia and New Zealand were taking BPM on admission, increasing to 22.4% in Australia and 27.8% in New Zealand on discharge. Registry patients who were younger (50-69 years), healthy (ASA grade 1), lived in a residential aged care facility, had impaired cognition, delirium identified, or were awaiting a specialist falls assessment were less likely to take BPM. Within the audit, 46.2% of patients in Australia and 39.2% in New Zealand did not have BPM in their discharge prescription. The most common reason for not prescribing BPM in Australia was low level of vitamin D (13.3%), and in New Zealand, renal impairment (14.8%). Sprint and registry patient characteristics were comparable in terms of patient age, sex, usual place of residence, and ASA grade.

conclusionsBPM prescription early after hip fracture is low. Opportunities exist to increase the rate of prescription of medications known to prevent future fractures in this high-risk population.

Indexed as

Bone Density Conservation AgentsHip FracturesOsteoporosisAustraliaDrug PrescriptionsHumansRetrospective StudiesBone Density Conservation AgentsAuditBone protection medicationHip fractureOsteoporosisRegistry

Identifiers

PMID36508017
OpenAlexW4311188420

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.